Axel Bolte
2019
In 2019, Axel Bolte earned a total compensation of $970.8K as President and Chief Executive Officer at Inozyme Pharma.
Compensation breakdown
| Bonus | $179,313 |
|---|---|
| Option Awards | $353,470 |
| Salary | $378,000 |
| Other | $60,000 |
| Total | $970,783 |
Bolte received $378K in salary, accounting for 39% of the total pay in 2019.
Bolte also received $179.3K in bonus, $353.5K in option awards and $60K in other compensation.
Rankings
In 2019, Axel Bolte's compensation ranked 9,401st out of 13,971 executives tracked by ExecPay. In other words, Bolte earned more than 32.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,401 out of 13,971 | 33rd |
Division Manufacturing | 3,771 out of 5,695 | 34th |
Major group Chemicals And Allied Products | 1,430 out of 2,194 | 35th |
Industry group Drugs | 1,219 out of 1,880 | 35th |
Industry Pharmaceutical Preparations | 906 out of 1,392 | 35th |
Source: SEC filing on April 27, 2021.
Bolte's colleagues
We found one more compensation record of an executive who worked with Axel Bolte at Inozyme Pharma in 2019.
2019
Henric Bjarke
Inozyme Pharma